| Offices: |
Washington DC Office
1101 Pennsylvania Ave.
Suite 600
Washington DC 20004
Telephone: 202-756-2972
|
Miami Office
1111 Brickell Avenue
11th Floor
Miami, FL 33131
Telephone: 305-913-7199
|
Fort Lauderdale Office
110 E. Broward Blvd.
Suite 1700
Fort Lauderdale, FL 33301
Telephone: 954-315-3934
Facsimile: 954-315-3914 |
|
|
Avandia News
GlaxoSmithKline to revise labeling for Avandia after EU regulator's decision
- CNN
01/24/2008 - GlaxoSmithKline PLC said is to revise the labeling on its Avandia diabetes product to include additional warnings that the product may be associated with an increased risk of heart attacks, after a decision by the European regulator (CHMP) today.
GSK said that the guidance will also state that the risk had not been confirmed in three separate clinical trials and that the overall data on heart attacks is inconclusive.
The warnings will state that the product should not be prescribed to patients with diagnosed heart disease or artery problems.
The FDA's 'black box' warning for Avandia has affected sales significantly in the US, with a fall of at least 30 pct during 2007.
Mike Ward at Nomura Code Securities said the decision had been widely expected with EU regulators bringing the product's safety information inline with those in the US.
If you or a loved one have experienced an Avandia heart attack, or Avandia stroke, Avandia congestive heart failure, Avandia cardiovascular disease or if you have lost a loved one to an Avandia death you may be entitled to compensation. Contact the Avandia lawyers of Ennis & Ennis, P.A. today about an Avandia lawsuit. Call us toll free for a free, confidential case evaluation or fill out our online Avandia case evaluation form. |
|
 |
About Us